Efficacy and safety of self-expanding metal stents in patients with inoperable esophageal cancer: a real-life study

Background: Dysphagia is the most frequent symptom in patients diagnosed with esophageal cancer. Self-expanding metal stents (SEMS) are the current palliative treatment of choice for dysphagia in patients with non-curable esophageal cancer. This study aimed to evaluate the efficacy and adverse event...

Full description

Bibliographic Details
Main Authors: José Miguel Jiménez-Gutiérrez, Juan Octavio Alonso-Lárraga, Angélica I. Hernández-Guerrero, Leonardo Saul Lino-Silva, Antonio Olivas-Martinez
Format: Article
Language:English
Published: SAGE Publishing 2023-09-01
Series:Therapeutic Advances in Gastrointestinal Endoscopy
Online Access:https://doi.org/10.1177/26317745231200975
_version_ 1797673300340506624
author José Miguel Jiménez-Gutiérrez
Juan Octavio Alonso-Lárraga
Angélica I. Hernández-Guerrero
Leonardo Saul Lino-Silva
Antonio Olivas-Martinez
author_facet José Miguel Jiménez-Gutiérrez
Juan Octavio Alonso-Lárraga
Angélica I. Hernández-Guerrero
Leonardo Saul Lino-Silva
Antonio Olivas-Martinez
author_sort José Miguel Jiménez-Gutiérrez
collection DOAJ
description Background: Dysphagia is the most frequent symptom in patients diagnosed with esophageal cancer. Self-expanding metal stents (SEMS) are the current palliative treatment of choice for dysphagia in patients with non-curable esophageal cancer. This study aimed to evaluate the efficacy and adverse events (AEs) of different types of SEMS for palliation of dysphagia. Methods: We performed a retrospective cohort study of patients with advanced esophageal cancer and SEMS placement for dysphagia palliation in a tertiary care center. The primary outcome was the clinical success defined as an improvement in dysphagia (reduction of at least 2 points in the Mellow–Pinkas scoring system for dysphagia) after SEMS placement. Results: Between January 1999 and May 2020, 295 patients with esophageal cancer were identified. Among them, 75 had a SEMS placement for dysphagia palliation. The mean age of the patients was 61.3 years (standard deviation: 13.4), 69 patients (92%) were men, and the mean Mellow–Pinkas scoring for dysphagia pre- and post-SEMS placement were 3.1 and 1.4 (change from baseline −1.7), respectively. Technical success and clinical success were achieved in 98.6% and 58.9%, respectively. AEs were identified in 35/75 patients (46.7%), and SEMS migration was the most frequent AE in 22/75 patients (29.3%). There were no significant differences in improvement in dysphagia ( p  = 0.054), weight changes ( p  = 0.78), and AE ( p  = 0.73) among fully covered SEMS (fc-SEMS) and partially covered SEMS (pc-SEMS). The median follow-up was 89 days (interquartile range: 29–221). Conclusion: SEMS placement was associated with a rapid improvement in dysphagia, high technical success, and a modest improvement in dysphagia with no major AE among fc-SEMS and pc-SEMS.
first_indexed 2024-03-11T21:42:33Z
format Article
id doaj.art-4085d0bc63da42f79da62ac04405c785
institution Directory Open Access Journal
issn 2631-7745
language English
last_indexed 2024-03-11T21:42:33Z
publishDate 2023-09-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Gastrointestinal Endoscopy
spelling doaj.art-4085d0bc63da42f79da62ac04405c7852023-09-26T12:33:22ZengSAGE PublishingTherapeutic Advances in Gastrointestinal Endoscopy2631-77452023-09-011610.1177/26317745231200975Efficacy and safety of self-expanding metal stents in patients with inoperable esophageal cancer: a real-life studyJosé Miguel Jiménez-GutiérrezJuan Octavio Alonso-LárragaAngélica I. Hernández-GuerreroLeonardo Saul Lino-SilvaAntonio Olivas-MartinezBackground: Dysphagia is the most frequent symptom in patients diagnosed with esophageal cancer. Self-expanding metal stents (SEMS) are the current palliative treatment of choice for dysphagia in patients with non-curable esophageal cancer. This study aimed to evaluate the efficacy and adverse events (AEs) of different types of SEMS for palliation of dysphagia. Methods: We performed a retrospective cohort study of patients with advanced esophageal cancer and SEMS placement for dysphagia palliation in a tertiary care center. The primary outcome was the clinical success defined as an improvement in dysphagia (reduction of at least 2 points in the Mellow–Pinkas scoring system for dysphagia) after SEMS placement. Results: Between January 1999 and May 2020, 295 patients with esophageal cancer were identified. Among them, 75 had a SEMS placement for dysphagia palliation. The mean age of the patients was 61.3 years (standard deviation: 13.4), 69 patients (92%) were men, and the mean Mellow–Pinkas scoring for dysphagia pre- and post-SEMS placement were 3.1 and 1.4 (change from baseline −1.7), respectively. Technical success and clinical success were achieved in 98.6% and 58.9%, respectively. AEs were identified in 35/75 patients (46.7%), and SEMS migration was the most frequent AE in 22/75 patients (29.3%). There were no significant differences in improvement in dysphagia ( p  = 0.054), weight changes ( p  = 0.78), and AE ( p  = 0.73) among fully covered SEMS (fc-SEMS) and partially covered SEMS (pc-SEMS). The median follow-up was 89 days (interquartile range: 29–221). Conclusion: SEMS placement was associated with a rapid improvement in dysphagia, high technical success, and a modest improvement in dysphagia with no major AE among fc-SEMS and pc-SEMS.https://doi.org/10.1177/26317745231200975
spellingShingle José Miguel Jiménez-Gutiérrez
Juan Octavio Alonso-Lárraga
Angélica I. Hernández-Guerrero
Leonardo Saul Lino-Silva
Antonio Olivas-Martinez
Efficacy and safety of self-expanding metal stents in patients with inoperable esophageal cancer: a real-life study
Therapeutic Advances in Gastrointestinal Endoscopy
title Efficacy and safety of self-expanding metal stents in patients with inoperable esophageal cancer: a real-life study
title_full Efficacy and safety of self-expanding metal stents in patients with inoperable esophageal cancer: a real-life study
title_fullStr Efficacy and safety of self-expanding metal stents in patients with inoperable esophageal cancer: a real-life study
title_full_unstemmed Efficacy and safety of self-expanding metal stents in patients with inoperable esophageal cancer: a real-life study
title_short Efficacy and safety of self-expanding metal stents in patients with inoperable esophageal cancer: a real-life study
title_sort efficacy and safety of self expanding metal stents in patients with inoperable esophageal cancer a real life study
url https://doi.org/10.1177/26317745231200975
work_keys_str_mv AT josemigueljimenezgutierrez efficacyandsafetyofselfexpandingmetalstentsinpatientswithinoperableesophagealcancerareallifestudy
AT juanoctavioalonsolarraga efficacyandsafetyofselfexpandingmetalstentsinpatientswithinoperableesophagealcancerareallifestudy
AT angelicaihernandezguerrero efficacyandsafetyofselfexpandingmetalstentsinpatientswithinoperableesophagealcancerareallifestudy
AT leonardosaullinosilva efficacyandsafetyofselfexpandingmetalstentsinpatientswithinoperableesophagealcancerareallifestudy
AT antonioolivasmartinez efficacyandsafetyofselfexpandingmetalstentsinpatientswithinoperableesophagealcancerareallifestudy